Drug Shortage Report for RIFADIN
| Report ID | 35644 |
| Drug Identification Number | 02091887 |
| Brand name | RIFADIN |
| Common or Proper name | Rifadin 150mg |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | RIFAMPIN |
| Strength(s) | 150MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100's |
| ATC code | J04AB |
| ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2018-01-05 |
| Estimated end date | 2018-01-30 |
| Actual end date | 2018-01-31 |
| Shortage status | Resolved |
| Updated date | 2018-02-02 |
| Company comments | Delay in supply |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-01-10 | English | Compare |
| v2 | 2018-01-10 | French | Compare |
| v3 | 2018-02-02 | English | Compare |
| v4 | 2018-02-02 | French | Compare |
Showing 1 to 4 of 4